Abstract:Sarcopenia has a high prevalence among the aging population. Sarcopenia is of tremendous socioeconomic importance because it can lead to falls and hospitalization, subsequently increasing healthcare costs while limiting quality of life. In sarcopenic muscle fibers, the E3 ubiquitin ligase F-Box Protein 32 (Fbxo32) is expressed at substantially higher levels, driving ubiquitin-proteasomal muscle protein degradation. As one of the key regulators of muscular equilibrium, the transcription factor Forkhead Box O3 (FOXO3) can increase the expression of Fbxo32, making it a possible target for the regulation of this detrimental pathway. To test this hypothesis, murine C2C12 myoblasts were transduced with AAVs carrying a plasmid for four specific siRNAs against Foxo3. Successfully transduced myoblasts were selected via FACS cell sorting to establish single clone cell lines. Sorted myoblasts were further differentiated into myotubes and stained for myosin heavy chain (MHC) by immunofluorescence. The resulting area was calculated. Myotube contractions were induced by electrical stimulation and quantified. We found an increased Foxo3 expression in satellite cells in human skeletal muscle and an age-related increase in Foxo3 expression in older mice in silico. We established an in vitro AAV-mediated FOXO3 knockdown on protein level. Surprisingly, the myotubes with FOXO3 knockdown displayed a smaller myotube size and a lower number of nuclei per myotube compared to the control myotubes (AAV-transduced with a functionless control plasmid). During differentiation, a lower level of FOXO3 reduced the expression Fbxo32 within the first three days. Moreover, the expression of Myod1 and Myog via ATM and Tp53 was reduced. Functionally, the Foxo3 knockdown myotubes showed a higher contraction duration and time to peak. Early Foxo3 knockdown seems to terminate the initiation of differentiation due to lack of Myod1 expression, and mediates the inhibition of Myog. Subsequently, the myotube size is reduced and the excitability to electrical stimulation is altered.

Single-nucleus profiling unveils a geroprotective role of the FOXO3 in primate skeletal muscle aging

SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing

Foxo3 Knockdown Mediates Decline of Myod1 and Myog Reducing Myoblast Conversion to Myotubes

FoxO maintains a genuine muscle stem-cell quiescent state until geriatric age

Identification of FOXO1 as a geroprotector in human synovium through single-nucleus transcriptomic profiling

Multiomics mapping and characterization of cellular senescence in aging human skeletal muscle uncovers a novel senotherapeutic for sarcopenia

Abstract 4910: Forkhead Transcription Factor 3a (foxo3a) is Involved in the Regulation of Functional Response to Aging and Stress in Murine Cardiomyocytes

Single nuclei profiling identifies cell specific markers of skeletal muscle aging, sarcopenia and senescence

FoxO3 Regulates Mouse Bone Mesenchymal Stem Cell Fate and Bone-Fat Balance During Skeletal Aging.

The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts

FOXO1 differentially regulates bone formation in young and aged mice

Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity

A Single-Cell Transcriptomic Landscape of Primate Arterial Aging.

Multimodal cell atlas of the ageing human skeletal muscle

SIRT2 counteracts primate cardiac aging via deacetylation of STAT3 that silences CDKN2B

FoxO1 Is a Novel Regulator of 20S Proteasome Subunits Expression and Activity

M6a Epitranscriptomic Regulation of Tissue Homeostasis During Primate Aging

The Neuromuscular Junction is a Focal Point of Mtorc1 Signaling in Sarcopenia

FOXP1 Controls Mesenchymal Stem Cell Commitment and Senescence During Skeletal Aging

Mass Spectrometry-Based Multiomics Identifies Metabolic Signatures of Sarcopenia in Rhesus Monkey Skeletal Muscle

A single-nucleus transcriptomic atlas of primate testicular aging reveals exhaustion of the spermatogonial stem cell reservoir and loss of Sertoli cell homeostasis